Lars Christer Fedrik Fåhraeus
Gründer bei CELLAVISION AB
Vermögen: 69 Mio $ am 30.04.2024
Aktive Positionen von Lars Christer Fedrik Fåhraeus
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
EQL PHARMA AB | Vorsitzender | 17.08.2022 | - |
Gründer | 01.01.2006 | - | |
Direktor/Vorstandsmitglied | 01.01.2006 | 17.08.2022 | |
Vorstandsvorsitzender | 01.01.2006 | 17.08.2022 | |
Präsident | 01.01.2006 | 17.08.2022 | |
CELLAVISION AB | Direktor/Vorstandsmitglied | - | - |
Gründer | 16.11.1994 | - | |
Independent Dir/Board Member | 16.11.1994 | - | |
Vorstandsvorsitzender | 16.11.1994 | - | |
CHECKIN.COM GROUP AB | Direktor/Vorstandsmitglied | 01.01.2023 | - |
Independent Dir/Board Member | 01.01.2023 | - | |
BioActive Polymers in Lund AB
BioActive Polymers in Lund AB BiotechnologyHealth Technology BioActive Polymers in Lund AB operates as bio-surgery focused company that offers product for abdominal and pelvic surgery. It develops BioBarrier, a post-surgical adhesion barrier spray. The firm's product is formulated to seek out and visibly self-bond specifically to the desired wound sites, perform its barrier function, and resorb. The company was founded by Gert Roland Andersson, Stig Bengmark, Björn Lindman, and Kåre Larsson in 1999 and is headquartered in Lund, Sweden. | Corporate Officer/Principal | - | - |
Bionamic AB
Bionamic AB Miscellaneous Commercial ServicesCommercial Services Bionamic AB is a Swedish company located in Lund. The firm engages in in life science, theoretical physics and software development activities. It was founded in 2019 by Anders Carlsson and Morten Krogh. Anders Carlsson has been the CEO since the inception date. | Vorsitzender | - | - |
Bizz Bike Sweden AB | Vorsitzender | - | - |
Eql Pharma Int AB | Direktor/Vorstandsmitglied | - | - |
Smältan Invest AB | Direktor/Vorstandsmitglied | - | - |
Theope Seed Capital AB | Direktor/Vorstandsmitglied | - | - |
░░░░░░ ░░░░░░░░░ ░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░░ ░░░░░░░░░░░░ ░░ | ░░░░░░░░ | - | - |
░░░░░░ ░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░░ ░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░░ ░░░░░░░ ░ ░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░ ░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░░░ ░░ | ░░░░░░░░ | - | - |
░░░░░░░░ ░░░░ ░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░ | - | - |
░░░░░░ ░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░░░ ░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░ | - | - | |
░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░ ░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░░ ░░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░ ░░░░░░░░░ ░░░░░░░ | - | - | |
░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░░░░ | - | - | |
░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Karriereverlauf von Lars Christer Fedrik Fåhraeus
Ehemalige bekannte Positionen von Lars Christer Fedrik Fåhraeus
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
░░░░ ░░░░░░ ░░ ░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░░ ░░░░░ ░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░░ ░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░ ░░░░░ ░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░░ ░░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░░░░░░ ░░ | ░░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░░ ░░ | ░░░░░░░░ | - | - |
░░░░░░ ░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░ ░░░░░░░░░░░ ░░░░░░░ ░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░ ░░░░░░░ ░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░░ ░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Ausbildung von Lars Christer Fedrik Fåhraeus
University of Lund | Doctorate Degree |
University of California San Diego | Graduate Degree |
Statistik
International
Schweden | 48 |
Vereinigte Staaten | 2 |
Operativ
Director/Board Member | 35 |
Chairman | 11 |
Founder | 8 |
Sektoral
Health Technology | 11 |
Electronic Technology | 6 |
Technology Services | 6 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 14 |
---|---|
INVISIO AB | Electronic Technology |
PRECISE BIOMETRICS AB | Electronic Technology |
KARO PHARMA AB (PUBL) | Health Technology |
ANOTO GROUP AB | Electronic Technology |
EQL PHARMA AB | Health Technology |
PHASE HOLOGRAPHIC IMAGING PHI AB | Health Technology |
CELLAVISION AB | Health Technology |
ARCEDE PHARMA AB | Commercial Services |
Health Technology | |
SERSTECH AB | Electronic Technology |
GASPOROX AB | Commercial Services |
AMNIOTICS AB | Health Technology |
SCANDIDOS AB | Technology Services |
CHECKIN.COM GROUP AB | Technology Services |
Private Unternehmen | 32 |
---|---|
Reccan Diagnostics AB
Reccan Diagnostics AB Pharmaceuticals: MajorHealth Technology Reccan Diagnostics AB provides cancer diagnosis and treatment. It offers tumor specific diagnosis, prognosis, prediction, and treatment selection with tumor specific directed therapy; and provides tumor-specific biomarkers for diagnosis and treatment selection. The company was founded by Gyorgy Marko-Varga, Roland Andersson, and Daniel Ansari and is headquartered in Lund, Sweden. | Health Technology |
Axiglaze AB | |
Agellis Group AB
Agellis Group AB Electronic Equipment/InstrumentsElectronic Technology Agellis Group AB designs, manufactures, and markets molten metal measurement systems. It offers steel making, ferrous and non-ferrous smelters, and continuous casting. The company was founded by Lars Christer Fedrik Fåhraeus on May 23, 2002 and is headquartered in Lund, Sweden. | Electronic Technology |
Lunds Universitets Utvecklingsbolag AB | |
Monkfish Instruments AB | |
Fårö Capital AB
Fårö Capital AB Investment ManagersFinance Fårö Capital AB provides business and management consultancy services. The company was founded on July 10, 2000 and is headquartered in Bjarred, Sweden. | Finance |
Fårö Capital Securities AB | |
Benehus Fastigheter AB | |
Fåhraeus Technology AB | |
Magistratsvägen 10 Holding AB | |
Valcuria AB
Valcuria AB Miscellaneous Commercial ServicesCommercial Services Valcuria AB engages in scientific and technical research and development. The private company is based in Lund, Sweden. The Swedish company was founded by Kristina Drott, Johan Drott. | Commercial Services |
Valcuria Holding AB | |
FlatFrog Laboratories AB
FlatFrog Laboratories AB Packaged SoftwareTechnology Services FlatFrog Laboratories AB designs and manufactures optics-based multi-touch kits and subsystems. Its product detects pressure, which creates ways for users to interact with content. The firm incorporates FlatFrog technology into products such as multi-touch tabletops, digital signage and whiteboards, point-of-sale, gaming and medical displays, and consumer electronics, such as note-/net-book computers, desktop monitors, and multi-touch input pads. The company was founded by Ola Wassvik and Lars Christer Fredrik Fåhraeus in 2007 and is headquartered in Lund, Sweden. | Technology Services |
Serstech Förvaltning AB | |
Smältan Invest AB | |
Bionamic Data Consulting AB | |
ApoEco Sverige AB | |
Bionamic AB
Bionamic AB Miscellaneous Commercial ServicesCommercial Services Bionamic AB is a Swedish company located in Lund. The firm engages in in life science, theoretical physics and software development activities. It was founded in 2019 by Anders Carlsson and Morten Krogh. Anders Carlsson has been the CEO since the inception date. | Commercial Services |
Bizz Bike Sweden AB | |
Eql Pharma Int AB | |
IntuiCell AB
IntuiCell AB Information Technology ServicesTechnology Services IntuiCell AB develops AI technology that mimics the human mind. The company is based in Lund, Sweden. The Swedish company was founded by Linus Mårtensson, Henrik Jörntell, Viktor Luthman, Udaya Rongala, Jonas Enander. Viktor Luthman has been the CEO since incorporation. | Technology Services |
BioActive Polymers in Lund AB
BioActive Polymers in Lund AB BiotechnologyHealth Technology BioActive Polymers in Lund AB operates as bio-surgery focused company that offers product for abdominal and pelvic surgery. It develops BioBarrier, a post-surgical adhesion barrier spray. The firm's product is formulated to seek out and visibly self-bond specifically to the desired wound sites, perform its barrier function, and resorb. The company was founded by Gert Roland Andersson, Stig Bengmark, Björn Lindman, and Kåre Larsson in 1999 and is headquartered in Lund, Sweden. | Health Technology |
Theope Seed Capital AB | |
Wranne Fåhraeus Design AB | |
Longboat Laboratories AB | |
Longboat Explorers AB | |
Melius Pharma AB
Melius Pharma AB Pharmaceuticals: MajorHealth Technology Melius Pharma AB is a Swedish clinical stage pharmaceutical company that develops new treatments for chronic cough in idiopathic pulmonary fibrosis (IPF) patients. The company is based in Lund, Sweden and is privately owned, benefiting from the support of two of Sweden's most prominent professional life science investors who bring expertise to develop the company. IPF is a chronic, progressive lung inflammation characterized by fibrosis and disruption of normal lung architecture. Melius Pharma has developed ME-015, which stabilizes ion channels in the neuronal endings in the lungs that mediate cough. ME-015 is presumed to have an acute effect and is a solution for chronic cough, which is one of the major symptoms experienced by 80%% of IPF patients. | Health Technology |
Fahraeus Startup & Growth | Finance |
CJ Scandinavian Seaview Consulting AB | |
Reccan AB
Reccan AB Medical SpecialtiesHealth Technology Reccan AB is a company headquartered in Lund, Sweden. The firm develops blood tests for pancreatic cancer diagnosis. It was founded in 2014 by György Marko-Varga and Roland Andersson. Malin Bornschein is the current CEO of the firm. | Health Technology |
Airsonett AB
Airsonett AB Medical DistributorsDistribution Services Airsonett AB is a holding company that is engaged in the research and development of a non-pharmaceutical treatment for asthma. Its product Airsonett is based on temperature controlled Laminar Airflow technology that creates a radically reduced allergen exposure in the breathing zone for treatment of asthma, allergic rhinitis, and atopic eczema. The company was founded by Jan Tommy Lennart Hedberg, Jan Kristensson, and Dan Kristensson in 2000 and is headquartered in Ängelholm, Sweden. | Distribution Services |
umanSense AB
umanSense AB Packaged SoftwareTechnology Services umanSense AB develops smart mobile software applications for medical and healthcare services. The company was founded by Johan Wasselius, Cecilia Belfrage and Petter Ericson and is headquartered in Lund, Sweden. | Technology Services |